Cleared Traditional

K970551 - QUANTA LITE B2GPI IGG (FDA 510(k) Clearance)

Jun 1997
Decision
132d
Days
Class 2
Risk

K970551 is an FDA 510(k) clearance for the QUANTA LITE B2GPI IGG. This device is classified as a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II - Special Controls, product code MSV).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on June 24, 1997, 132 days after receiving the submission on February 12, 1997.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K970551 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 1997
Decision Date June 24, 1997
Days to Decision 132 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MSV — System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660